Evelina Marchesoni

I specialise in multi-jurisdictional contentious patent matters, with a particular focus on Life Sciences & Healthcare and the Tech & Comms sector.

When I joined Bird & Bird in 2005, I was involved in a broad range of intellectual property tasks, including patents, trademarks, designs, domain names and unfair competition, both in contentious and non-contentious matters, for clients active in different sectors.

I then specialised in patent litigation in the life sciences sector. In particular, on a daily basis, I am involved in pan-European litigation related to pharmaceutical and biotechnological patents and supplementary protection certificates and patents on medical devices.

I am also experienced in patent litigation in the telecommunications sector. In particular, I have been involved in various litigations concerning standard essential patents but also in defining the strategy of protection and enforcement of these patents and in managing the related competition issues.

I have contributed to various legal publications and articles on intellectual property law (including Managing Intellectual Property Magazine, The Life Sciences Law Review, Life Sciences Legal Practice Guide, Studi in memoria di Paola A .E. Frassi, Kluwer Trademark Litigation Smart Charts), and I'm a member of the Editorial Board of EPLAW Patent Blog and of the European Copyright and Design Reports (Sweet & Maxwell).

• Assisting pharmaceutical companies in different proceedings - preliminary injunction, invalidity and infringement, 'descrizione' - related to pharmaceutical and biotechnological patents and supplementary protection certificates, including patents on pemetrexed, fulvestrant formulation, tadalafil dosage regimen, rivastigmine patch, esomeprazole, rosuvastatin, quietiapine extended release, paracetamol and tramadol, second medical use of botulinum toxin, bimatoprost, fluvastatin, nebivolol, olanzapine, finasteride, rituximab, natalizumab dosage regimen and the SPCs on telmisartan and hydrochlorothiazide, valsartan and hydrochlorothiazide, ezetimibe and simvastatin.
• Assisting a biotechnology company in preliminary injunction and infringement and invalidity proceedings related to a patent for DNA sequencing technology.
• Assisting a medical devices manufacturer in preliminary injunction proceedings related to a patent on breathing tubes.
• Assisting different companies in in the strategy and enforcement of standard essential patents, including patents related to GSM, 3G, LTE, Wi-Fi, DVB-T2, ATSS and WSS technology.
• Assisting a Fortune 100 company in proceedings for invalidity and infringement of a patent related to an automobile air conditioning refrigerant.
• Assisting a company active in the global outdoor apparel and footwear in preliminary injunction proceedings related to a patent on a waterproof-breathable footwear.
• Assisting a company active in the mechanical sector in 'torpedo' action for non-infringement of foreign patents and different designation of a European patent.
• Advising a pharmaceutical company on Italian issues arising from a patent litigation pending in the UK where the English judges exercised jurisdiction over claims for non-infringement (also) of the Italian designation of a European patent.
• Advising a company leader in the luxury and fashion sector on a range of brand and product design protection and enforcement issues.